Concert Pharmaceuticals (CNCE) is developing innovative medicines with deuterium chemistry (heavy hydrogen) to address the needs of patients with chronic diseases. That's over my pay grade but the charts are interesting. Let's check it out.




Concert Pharmaceuticals (CNCE) is developing innovative medicines with deuterium chemistry (heavy hydrogen) to address the needs of patients with chronic diseases. That's over my pay grade but the charts are interesting. Let's check it out.
It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania.
Short selling is a powerful tool, but it is not just the inverse of going long and requires a very different mindset to do it effectively.
I believe the markets are headed lower - probably not in a straight line or as steep as the last few days, but in a saw tooth fashion lower.
It is premature to declare that the worst is over, but the intensity of the selling will go a long way toward helping a bottom to form.
TWLO could bounce in the short-run but avoid the long side for now.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login